menu search

TFFP / TFF Pharmaceuticals to Participate in Upcoming Investor Conferences

TFF Pharmaceuticals to Participate in Upcoming Investor Conferences
FORT WORTH, Texas, Sept. 28, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing technology platform, today announced that CEO Harlan Weisman, M.D. will attend and hold one-on-one investor meetings at the upcoming Jones Trading 2023 Healthcare Summit. Dr. Weisman will also present and hold one-on-one investor meetings at the upcoming Roth MKM 2023 Healthcare Opportunities Conference. Read More
Posted: Sep 28 2023, 16:29
Author Name: GlobeNewsWire
Views: 111699

TFFP News  

TFF Pharmaceuticals to Participate in Upcoming Investor Conferences

By GlobeNewsWire
September 28, 2023

TFF Pharmaceuticals to Participate in Upcoming Investor Conferences

FORT WORTH, Texas, Sept. 28, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on more_horizontal

3 Bargain Stocks Worth Buying at These 52-Week Lows

By InvestorPlace
February 23, 2023

3 Bargain Stocks Worth Buying at These 52-Week Lows

Who doesn't love a bargain? We look for deals in many places. more_horizontal

TFF Pharmaceuticals: From Undefeatable To Speculative

By Seeking Alpha
November 22, 2022

TFF Pharmaceuticals: From Undefeatable To Speculative

Almost everything has gone wrong since my first bullish article with TFF Pharmaceuticals. The stock is now severely depressed and, despite significant more_horizontal

TFF Pharmaceuticals, Inc. (TFFP) Q3 2022 Earnings Call Transcript

By Seeking Alpha
November 14, 2022

TFF Pharmaceuticals, Inc. (TFFP) Q3 2022 Earnings Call Transcript

TFF Pharmaceuticals, Inc. (NASDAQ:TFFP ) Q3 2022 Earnings Conference Call November 14, 2022 5:00 PM ET Company Participants Corey Davis - LifeSci Advi more_horizontal

TFF Pharma: The Potential Is Still Very Much Present

By Seeking Alpha
August 29, 2022

TFF Pharma: The Potential Is Still Very Much Present

While the company added three more big pharma partners, this is not what shareholders prefer to hear as the company already has more than two dozen of more_horizontal

TFF Pharmaceuticals: Q3 Data Is Pivotal In So Many Ways

By Seeking Alpha
August 9, 2022

TFF Pharmaceuticals: Q3 Data Is Pivotal In So Many Ways

Once promising, TFF Pharma is now cash-strapped and stagnant. TFFP badly needs some good news. more_horizontal

TFF Pharmaceuticals: A Highly Attractive Basket Of Options

By Seeking Alpha
May 23, 2022

TFF Pharmaceuticals: A Highly Attractive Basket Of Options

TFFP is a platform company with leading technology. Clinical/FDA risk is extremely low. more_horizontal

TFF Pharmaceuticals, Inc. (TFFP) CEO Glenn Mattes on Q1 2022 Results - Earnings Call Transcript

By Seeking Alpha
May 11, 2022

TFF Pharmaceuticals, Inc. (TFFP) CEO Glenn Mattes on Q1 2022 Results - Earnings Call Transcript

TFF Pharmaceuticals, Inc. (NASDAQ:TFFP ) Q1 2022 Earnings Conference Call May 11, 2022 4:30 PM ET Company Participants Corey Davis - LifeSci Advisors more_horizontal


Search within

Pages Search Results: